Dawnrays Pharmaceutical Holdings Ltd. announced that Ms. Huang Dongmei resigned as the Chief Executive Officer with effect from 1 March 2015; and (ii) Ms. Li Kei Ling was appointed as the Chief Executive Officer with effect from 1 March 2015. Ms. Li is also an executive director and the chairman of the Board of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 HKD | 0.00% | 0.00% | +12.38% |
1st Jan change | Capi. | |
---|---|---|
+12.38% | 227M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 2348 Stock
- News Dawnrays Pharmaceutical (Holdings) Limited
- Dawnrays Pharmaceutical Holdings Ltd. Announces Executive Changes, Effective March 31, 2015